Calciphylaxis Secondary to Vitamin D Supplementation

Calciphylaxis is a rare cutaneous disease consisting of purpuric and necrotic lesions, and it affects mostly patients with renal failure. More rarely, it can be observed in patients with preserved renal function, acquiring the name of non-uremic calciphylaxis (NUC). Although its pathophysiology is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa e Silva, Joana, Ramos, José N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556987/
https://www.ncbi.nlm.nih.gov/pubmed/37809218
http://dx.doi.org/10.7759/cureus.44778
_version_ 1785116989910417408
author Costa e Silva, Joana
Ramos, José N
author_facet Costa e Silva, Joana
Ramos, José N
author_sort Costa e Silva, Joana
collection PubMed
description Calciphylaxis is a rare cutaneous disease consisting of purpuric and necrotic lesions, and it affects mostly patients with renal failure. More rarely, it can be observed in patients with preserved renal function, acquiring the name of non-uremic calciphylaxis (NUC). Although its pathophysiology is under uncertainty, many etiological factors have been implicated. This report describes a patient who developed NUC, possibly triggered by vitamin D supplementation.
format Online
Article
Text
id pubmed-10556987
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105569872023-10-07 Calciphylaxis Secondary to Vitamin D Supplementation Costa e Silva, Joana Ramos, José N Cureus Dermatology Calciphylaxis is a rare cutaneous disease consisting of purpuric and necrotic lesions, and it affects mostly patients with renal failure. More rarely, it can be observed in patients with preserved renal function, acquiring the name of non-uremic calciphylaxis (NUC). Although its pathophysiology is under uncertainty, many etiological factors have been implicated. This report describes a patient who developed NUC, possibly triggered by vitamin D supplementation. Cureus 2023-09-06 /pmc/articles/PMC10556987/ /pubmed/37809218 http://dx.doi.org/10.7759/cureus.44778 Text en Copyright © 2023, Costa e Silva et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Costa e Silva, Joana
Ramos, José N
Calciphylaxis Secondary to Vitamin D Supplementation
title Calciphylaxis Secondary to Vitamin D Supplementation
title_full Calciphylaxis Secondary to Vitamin D Supplementation
title_fullStr Calciphylaxis Secondary to Vitamin D Supplementation
title_full_unstemmed Calciphylaxis Secondary to Vitamin D Supplementation
title_short Calciphylaxis Secondary to Vitamin D Supplementation
title_sort calciphylaxis secondary to vitamin d supplementation
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556987/
https://www.ncbi.nlm.nih.gov/pubmed/37809218
http://dx.doi.org/10.7759/cureus.44778
work_keys_str_mv AT costaesilvajoana calciphylaxissecondarytovitamindsupplementation
AT ramosjosen calciphylaxissecondarytovitamindsupplementation

Ejemplares similares